Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Pablo Reclusa being referenced
FGFR a promising druggable target in cancer: Molecular biology and new drugs
2017
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Pablo Reclusa | 546 | 460 | 194 | 15 | 745 | |
| Sabine Hellwig | 447 | 502 | 170 | 18 | 777 | |
| S. Duygu Selçuklu | 699 | 546 | 144 | 15 | 886 | |
| Qingbei Zhang | 439 | 264 | 289 | 17 | 839 | |
| J.S. de Jong | 442 | 295 | 183 | 12 | 843 | |
| Gonzalo Lopez | 497 | 199 | 171 | 20 | 708 | |
| Marta Rodríguez | 714 | 608 | 121 | 18 | 849 | |
| Xia Xu | 488 | 447 | 73 | 20 | 698 | |
| Anna Babayan | 433 | 512 | 107 | 12 | 725 | |
| Allison Hills | 409 | 597 | 209 | 12 | 833 | |
| Salvador Mejia‐Guerrero | 633 | 447 | 200 | 14 | 828 |
All Works
Login with ORCID to disown or claim papers
Loading papers...